Literature DB >> 21602257

Prevalence of abdominal wall hernia in participants with abdominal aortic aneurysm versus peripheral arterial disease--a population-based study.

Rajmony Pannu1, Ian R McPhail.   

Abstract

Small studies suggest an association between abdominal aortic aneurysms (AAAs) and hernias, possibly related to connective tissue weakness. We evaluated the association between AAA and abdominal wall hernia (AWH), using peripheral arterial disease (PAD) patients as controls, in Olmsted County, Minnesota. In a retrospective cohort study we queried the electronic medical records for the diagnosis of AAA. The resulting data were then queried for prevalence of AWH. The same set of queries was repeated for PAD. Occurrence of AWH in the 2 groups was compared using the chi-square test. Of the 187 151 patient records queried, 939 had AAA and 3465 had PAD. Abdominal wall hernia occurred in 157 (16.7%) patients with AAA and in 343 (9.9%) patients with PAD. Abdominal wall hernia was 1.7 times more prevalent in those with AAA versus PAD (P < .0001). A history of hernia may prompt screening for AAA in some patients.

Entities:  

Mesh:

Year:  2011        PMID: 21602257     DOI: 10.1177/0003319711409922

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  3 in total

1.  Does perfusion matter? Preoperative prediction of incisional hernia development.

Authors:  B O Aicher; J Woodall; B Tolaymat; C Calvert; T S Monahan; S Toursavadkohi
Journal:  Hernia       Date:  2019-08-02       Impact factor: 4.739

2.  Association between thoracic aortic disease and inguinal hernia.

Authors:  Christian Olsson; Per Eriksson; Anders Franco-Cereceda
Journal:  J Am Heart Assoc       Date:  2014-08-21       Impact factor: 5.501

3.  Incidence and risk factors for incisional hernia after abdominal aortic aneurysm and aortic occlusive disease surgery.

Authors:  Volkan Sayur; Erkan Güler; Hakan Posacıoğlu; Taylan Özgür Sezer; Özgür Fırat; Muhtar Sinan Ersin
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-10-20       Impact factor: 0.332

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.